R&D

  • overview
  • Technologies
  • R&D Pipeline
  • Open Innovation
  • Achivement

Open Innovation Open Innovation

Samyang Biopharm is looking for innovative technology through open innovation. Open innovation belongs to those who are in the industry, academia, and research field. Samyang Biopharm is looking for innovative technology through open innovation. Open innovation belongs to those who are in the industry, academia, and research field. Samyang Biopharm will continue to innovate the R&D with together with industry, academia, and research.

Samyang Biopharm Image 삼양바이오팜 산학연 이미지

라이선스 아웃 (Out-Licensing) 라이선스 아웃 (Out-Licensing)

Samyang Biopharmaceuticals Corp. has established the platform of our unique drug delivery technology and is developing siRNA, immuno-oncology and oncolytic virus via the application of such technology. Presently Currently, Samyang Biopharmaceutical Corp. is seeking technology transfer or partners interested in joint development.

라이선스 인 (In-Licensing) 라이선스 인 (In-Licensing)

Samyang Biopharmaceuticals Corp. is looking for a company that has unique technology and products applicable to the anticancer fields such as immuno-oncology and the oncolytic virus. Samyang Biopharmaceuticals Corp. has already opened devised various cooperation models such as joint research, commissioned research, technology transfer, investment, joint venture, and M&A in the anticipation of successful partnership

Collaboration Collaboration

Samyang Biopharmaceuticals Corp. seeks active collaboration with specialized CROs, CMOs, and consultants with competence and experience in pre-clinical, clinical and production research as well as technology transfer.

Contact us
If you need further information on open innovation, please get in touch with us.